Legend Biotech (LEGN) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Legend Biotech (LEGN) is Neutral.

The composite score behind that read is +0.08, weighing +0.21 of bullish evidence against -0.21 bearish.

Legend Biotech last closed at $18.62, -0.48% on the session.

Against the IVW growth benchmark the position is -1.28% over the forecast window.

The read is built from 15 underlying insights — 9 bullish and 6 bearish.

Agreement across those insights is 60%.

1 graded prediction for LEGN so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Legend Biotech in the 32nd percentile on return on equity, where 100 is best.

Legend Biotech is classified under Health Care / Biotechnology, with a market capitalisation of $3.64B.

StockMap tracks Legend Biotech as the 59th largest of the 381 companies it covers in the Biotechnology industry, part of the Health Care sector.

Across that group the current two-week reads are 301 Neutral, 63 Moderate Underperform and 17 Moderate Outperform.

On that composite Legend Biotech ranks 54th of 381 in the group, against a group median of -0.08.